GSK revenue by division 2024| ��ƽ��

Revenue of GSK from 2006 to 2024, by division (in million British pounds)

Characteristic	Pharmaceuticals and Vaccines	Consumer Healthcare	Specialty Medicines**	General Medicines**	Vaccines**
2024	-	-	11,810	10,428	9,138
2023	-	-	10,244	10,220	9,864
2022**	-	-	11,269	10,118	7,937
2021	24,507	9,607	-	-	-
2020	24,038	10,033	-	-	-
2019	24,711	8,995	-	-	-
2018	23,163	7,658	-	-	-
2017	22,436	7,750	-	-	-
2016*	20,696	7,193	-	-	-
2015*	17,813	6,038	-	-	-
2014*	18,597	4,322	-	-	-
2013*	20,743	4,713	-	-	-
2012*	20,645	4,731	-	-	-
2011	21,894	5,403	-	-	-
2010	23,284	5,108	-	-	-
2009	23,653	4,715	-	-	-
2008	20,381	3,971	-	-	-
2007	19,163	3,553	-	-	-
2006	20,013	3,212	-	-	-

Download

Source

Show detailed source information?

Already a member?

Source

Release date

February 2025

More information

Region

Worldwide, United Kingdom

Survey time period

2006 to 2024

Supplementary notes

This statistic was assembled from several editions of the GSK Annual Report.
* Values for these years are restated.
** Reflects the spin-off of the Consumer Healthcare business. In the same year, GSK restructured and renamed its divisions (product groups).

Citation formats

This statistic shows the revenue of pharmaceutical company GSK (GlaxoSmithKline) from 2006 to 2024, sorted by division. GSK plc is one of the largest pharmaceutical companies worldwide. The multinational company is headquartered in London, UK. In 2024, the company generated revenues of some 11.8 billion British pounds with specialty medicines. During 2022, the company spun-off its Consumer Healthcare business, focusing on pharmaceuticals and R&D. In the course of the spin-off, GSK also restructured and renamed its business divisions.